Integra Lifesciences (NASDAQ: IART) reported quarterly earnings of $0.45 per share which beat the analyst consensus estimate of $0.43 by 4.17 percent. This is a 28.57 percent decrease over earnings of $0.63 per share from the same period last year. The company reported quarterly sales of $415.605 million which beat the analyst consensus estimate of $395.067 million by 5.20 percent. This is a 0.61 percent decrease over sales of $418.175 million the same period last year.